Bunkerhill AVC vs Reveal LINQ
AI Verdict
Choose Bunkerhill AVC if…
Choose Bunkerhill AVC if your health system aims to leverage existing chest CT scans for opportunistic screening and early detection of cardiovascular risks like aortic valve calcification. This tool is ideal for integrating AI-powered analysis directly into EHR workflows to proactively identify at-risk patients and automate the quantification of various calcifications.
View Bunkerhill AVC →Choose Reveal LINQ if…
Choose Reveal LINQ if you need a long-term, continuous cardiac monitoring solution for patients experiencing infrequent or unexplained symptoms suggestive of arrhythmias, such as cryptogenic stroke or syncope. This implantable device provides up to three years of ECG recording with AI-powered accuracy to definitively diagnose elusive cardiac events.
View Reveal LINQ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill AVC | Reveal LINQ |
|---|---|---|
| Deployment | Unknown | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Bunkerhill AVCBunkerhill AVC integrates directly into existing Electronic Health Records (EHRs) and leverages natural language processing, streamlining clinical workflows and potentially offering a more seamless user experience for clinicians within their familiar environment. Reveal LINQ, while offering a mobile app for clinicians, involves an invasive procedure and a separate patient monitoring system, introducing additional layers of interaction.
Clinical Value
TieBoth tools offer significant clinical value in distinct ways. Bunkerhill AVC provides broad, opportunistic screening for multiple conditions from existing imaging data, potentially impacting a wider patient population without additional procedures. Reveal LINQ offers critical, long-term, continuous monitoring for elusive cardiac arrhythmias, which is invaluable for specific diagnostic challenges.
Pricing & Value
Reveal LINQWhile both tools require direct contact for pricing, Medtronic's Reveal LINQ explicitly states that its costs are typically negotiated and often covered by insurance, which provides a clearer path to reimbursement and potentially better value for healthcare providers and patients. Bunkerhill AVC's pricing model and reimbursement pathways are not detailed in the provided information.
Enterprise Readiness
Bunkerhill AVCBunkerhill AVC is designed for deep integration with existing EHRs and clinical archives, offering customizable AI agents for diverse workflows, making it highly adaptable to a health system's IT infrastructure. Reveal LINQ, while a robust medical device from a major enterprise, operates with its own ecosystem of device, monitor, and app, which represents a different integration challenge compared to a software platform.
Innovation
TieBoth tools represent significant innovation in their respective domains. Bunkerhill AVC leverages cutting-edge generative AI and natural language processing for clinical reasoning and opportunistic diagnostics. Reveal LINQ demonstrates innovation in medical device miniaturization, long-term continuous monitoring, and AI-driven accuracy for detecting elusive cardiac arrhythmias.
Support & Docs
Reveal LINQMedtronic, as an established medical device company, offers comprehensive and easily accessible support and documentation for Reveal LINQ, including detailed manuals, patient education resources, and dedicated technical and patient service lines. Bunkerhill Health's public information does not detail a comparable level of explicit support and documentation resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill AVC | Reveal LINQ |
|---|---|---|
| Name | Bunkerhill AVC | Reveal LINQ |
| Company | BunkerHill Health | Medtronic |
| Primary Function | Generative AI platform for clinical reasoning and action, specifically early detection and quantification of aortic valve calcification from chest CTs. | Tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AI algorithms to accurately detect and diagnose cardiac arrhythmias. |
| Core AI Application | Automated detection and quantification of aortic valve calcification (Bunkerhill AVC), coronary artery calcification (iCAC, Contrast CAC), mitral annular calcification (Bunkerhill MAC), and opportunistic bone density assessment (Bunkerhill BMD). | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause) in continuous ECG monitoring for arrhythmia detection. |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Form Factor | Generative AI platform/software | Implantable cardiac monitor |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill AVC and Reveal LINQ.